Exagen company info

What does Exagen do?
Exagen (NASDAQ:XGN) is a health services company focused on transforming the care continuum for patients suffering from autoimmune diseases. By deploying a combination of unique testing services and proprietary technologies, Exagen aims to empower physicians with precise diagnostic, prognostic, and therapeutic solutions. The company is committed to advancing the field of autoimmune diagnostics through ongoing research and development projects, striving to uncover new insights and innovations that can improve patient outcomes. Exagen's principal objective is to enhance the quality of life for those affected by autoimmune conditions by providing accurate, early detection and facilitating targeted treatment strategies.
Exagen company media
Company Snapshot

Is Exagen a public or private company?

key
Ownership
Public

How many people does Exagen employ?

people
Employees
177

What sector is Exagen in?

pie chart
Sector
Health Care

Where is the head office for Exagen?

location pin
Head Office
Vista, United States

What year was Exagen founded?

founded flag
Year Founded
2002
What does Exagen specialise in?
/Medical Diagnostics /Autoimmune Testing /AVISE Tests /Personalized Medicine /Lupus Diagnostics /Patient Care

What are the products and/or services of Exagen?

Overview of Exagen offerings
AVISE CTD test for differential diagnosis of connective tissue diseases, aiding in accurate diagnosis of lupus and other autoimmune diseases.
AVISE Lupus test, designed specifically to aid in the diagnosis of systemic lupus erythematosus (SLE), offering high sensitivity and specificity.
AVISE APS, a testing solution for antiphospholipid syndrome (APS), providing vital information for risk assessment and management of this autoimmune disorder.
AVISE SLE Monitor, a comprehensive monitoring tool for managing systemic lupus erythematosus, enabling personalized treatment adjustments.
AVISE MCV, a biomarker test for measuring the activity of rheumatoid arthritis, assisting in disease management and treatment decision-making.
AVISE PG, a pharmacogenetic testing service that guides the effective use of certain medications in individual patients, aiming at personalized medicine.

Who is in the executive team of Exagen?

Exagen leadership team
  • Dr. Tina S. Nova Ph.D.
    Dr. Tina S. Nova Ph.D.
    Executive Chairman of the Board of Directors
  • Mr. John  Aballi
    Mr. John Aballi
    CEO, President & Director
  • Mr. Kamal  Adawi M.S., MBA
    Mr. Kamal Adawi M.S., MBA
    CFO & Corporate Secretary
  • Ryan  Douglas
    Ryan Douglas
    Investors Relations Officer
  • Mr. John  Wegener
    Mr. John Wegener
    Senior Vice President of Sales and Marketing
  • Dr. Andrew L. Concoff FACR, M.D.
    Dr. Andrew L. Concoff FACR, M.D.
    Chief Innovation Officer & Member of Rheumatoid Arthritis Scientific Advisory Board
  • Dr. Michael I. Nerenberg M.D.
    Dr. Michael I. Nerenberg M.D.
    Chief Medical Officer